Fenwick-Led Biotech Firm Joins Early 2020 IPO Hopefuls
Skin disease-focused Arcutis Biotherapeutics Inc. filed a $100 million initial public offering Monday, guided by Fenwick & West LLP and underwriters counsel Latham & Watkins LLP, joining a wave of health...To view the full article, register now.
Already a subscriber? Click here to view full article